Medicared For All Logo

Michael Raizner MD in Houston, Texas

Home Texas Houston

Michael Raizner MD has Cardiovascular Disease (cardiology) as his primary medical specialty. Their primary office is: 6550 Fannin St in Houston, Texas. There is an additional office location, for a total of two, for Michael Raizner MD that can be viewed further down.

They're a part of the: Interventional Cardiology Associates medical group which has around 5 members. You can call their office at 713-790-9125 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Baylor College Of Medicine and graduated in 1998 (around 26 years of experience). They are listed as doing telehealth appointments.


Michael E Raizner MD Office Phone and Directions

Michael Raizner MD
Interventional Cardiology Associates
6550 Fannin St
Houston, Texas 77030
713-790-9125


Patient Ratings
Please rate your experience with Michael Raizner MD below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 713-790-9125


Enter a starting address:


Healthcare Info for Michael Raizner MD

Additional Medical Specialties Include:
INTERNAL MEDICINE, INTERVENTIONAL CARDIOLOGY

Medical School: Baylor College Of Medicine
Graduation Year: 1998
The Primary Medical Specialty for Michael Raizner MD is listed as: Cardiovascular Disease (cardiology)
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 26
PAC (PECOS ID)#: 3476599531
NPI #: 1417931155
NPI Created On: 12/06/2005
NPI Last Updated Listed as: 06/26/2008
Primary Taxonomy Code: 207RC0000X
License Number:
L5105
Listed Gender: Male

Insurance, Services, Charges


Forms of insurance accepted by include, but are not limited to:

  • Humana
  • Blue Cross Blue Shield
  • Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Spanish.


Services and Procedures include:

  1. Nuclear medicine study of vessels of heart using drugs or exercise multiple studies
  2. Routine ekg using at least 12 leads including interpretation and report
  3. Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician supervision, interpretation, and report
  4. Heart rhythm tracing of 48-hour ekg
  5. Heart rhythm tracing, analysis, and interpretation of 48-hour ekg
  6. Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function
  7. Insertion of catheter for imaging of heart blood vessels or grafts
  8. Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 15 minutes
  9. New patient office or other outpatient visit, typically 45 minutes
  10. Established patient office or other outpatient visit, typically 15 minutes
  11. Established patient office or other outpatient, visit typically 25 minutes
  12. Established patient office or other outpatient, visit typically 40 minutes
  13. Initial hospital inpatient care, typically 70 minutes per day
  14. Subsequent hospital inpatient care, typically 25 minutes per day
  15. Subsequent hospital inpatient care, typically 35 minutes per day
  16. Critical care delivery critically ill or injured patient, first 30-74 minutes
  17. Physician telephone patient service, 11-20 minutes of medical discussion
  18. Technetium tc-99m tetrofosmin, diagnostic, per study dose
  19. Injection, regadenoson, 0.1 mg

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788216637

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Drug or Biological: Drug

Product Category #2: Cardiovascular & Metabolism

Name Of Drug #2:: INVOKANA

Associated Drug #2: 50458-140-30


Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788216639

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30


Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788216641

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30


Payments Total: $34

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 768827336

Being Disputed:: No

Product Related: Yes

Drug or Biological: Device

Product Category #1: Electromedical and Electrotherapeutic Apparatus

Name of Drug #1: LifeVest


Payments Total: $11

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 825614917

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Cardiology

Name of Drug #1: Repatha

Open Associated Drug #1: 72511-760-02


Payments Total: $18

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 825614921

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Cardiology

Name of Drug #1: Repatha

Open Associated Drug #1: 72511-760-02


Payments Total: $21

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 843563497

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiology/Vascular Diseases

Name of Drug #1: MULTAQ

Open Associated Drug #1: 0024-4142-10


Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 821505115

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: HOSPITAL AND TRANSPLANT

Name of Drug #1: LEXISCAN

Open Associated Drug #1: 0469-6501-89


Additional Office Locations

1. Interventional Cardiology Associates
16659 Southwest Fwy
Sugar Land, TX 77479
Suite 215
Group Members: 5

Phone: 713-790-9125

Enter a starting address:


Cardiovascular Disease (cardiology) Professionals in Houston

1200 Binz St
Houston, TX
Specialty Associates Of West Houston Pllc

1801 N Loop W
Houston, TX
Memorial Hermann Medical Group

1635 N Loop W
Houston, TX
Memorial Hermann Medical Group

915 Gessner Rd
Houston, TX
Memorial Hermann Medical Group

1631 N Loop W
Houston, TX
Memorial Hermann Medical Group

13325 Hargrave Rd
Houston, TX
Heart Care Center Of Northwest Houston Pa

Providers in Interventional Cardiology Associates

1.Clement Defelice Jr.

6550 Fannin St
Houston Tx 77030-2709
Interventional Cardiology Associates
Cardiovascular Disease (cardiology)

2.Mohamed El Beheary Md

6550 Fannin St
Houston Tx 77030-2709
Interventional Cardiology Associates
Cardiovascular Disease (cardiology)

3.Mohamed El Beheary Md

16659 Southwest Fwy
Sugar Land Tx 77479-2372
Interventional Cardiology Associates
Cardiovascular Disease (cardiology)

4.Albert Raizner

6550 Fannin St
Houston Tx 77030-2709
Interventional Cardiology Associates
Cardiovascular Disease (cardiology)

5.Michael Raizner Md

6550 Fannin St
Houston Tx 77030-2709
Interventional Cardiology Associates
Cardiovascular Disease (cardiology)

6.Michael Raizner Md

16659 Southwest Fwy
Sugar Land Tx 77479-2372
Interventional Cardiology Associates
Cardiovascular Disease (cardiology)

View all 5 members of Interventional Cardiology Associates medical group